RXCHANGE

DEAD

Serial Number

98149283

Owner

National Community Oncology Dispensing Association, Inc.

Attorney

Jeffrey Mustari, Esq.

First Use Date

Aug 16, 2022

Filing Date

Aug 24, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

RXCHANGE Trademark

Serial Number: 98149283

RXCHANGE is a trademark filed by National Community Oncology Dispensing Association, Inc. on August 24, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

National Community Oncology Dispensing Association, Inc. (12 trademarks)

5345 Indian Lookout Road
Cazenovia, NY 13035

Entity Type: 03

Legal Representation

Attorney of Record

Jeffrey Mustari, Esq.

13 trademarks filed View all →

Trademark Details

Filing Date

August 24, 2023

Registration Date

Not Registered

First Use Anywhere

August 16, 2022

First Use in Commerce

August 16, 2022

Goods & Services

Medical and scientific research in the field of cancer treatment and diagnosis; Providing information about medical research in the field of pharmaceuticals offered via a dispensing pharmacy within an oncology center of excellence

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Nov 23, 2024 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 23, 2024 ABN2

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Aug 8, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Aug 8, 2024 XELR

NOTIFICATION OF FINAL REFUSAL EMAILED

May 9, 2024 GNFN

FINAL REFUSAL E-MAILED

May 9, 2024 GNFR

FINAL REFUSAL WRITTEN

May 9, 2024 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

May 1, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 30, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 30, 2024 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jan 29, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jan 29, 2024 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 30, 2023 GNRN

NON-FINAL ACTION E-MAILED

Oct 30, 2023 GNRT

NON-FINAL ACTION WRITTEN

Oct 30, 2023 CNRT

ASSIGNED TO EXAMINER

Oct 30, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2023 NWOS

NEW APPLICATION ENTERED

Aug 28, 2023 NWAP

Related Trademarks

More from this Owner

NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION

More in Same Class

PATH TO PLAN

BENCHMARK LEAKAGE POINT OF CARE SOLUTIONS

TISENTO THERAPEUTICS

HAKKODA

OVISTO

GAMEMATE